Clinical trial results of GEM91 show activity against advance HIV.
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*; D012367:RNA, Viral / Q000097:blood / Q000187:drug effects; D013873:Thionucleotides / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense; D012367:RNA, Viral; D013873:Thionucleotides; C079996:GEM91